511 related articles for article (PubMed ID: 4038714)
21. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Harrelson JM; Drezner MK
J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
[No Abstract] [Full Text] [Related]
22. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
[TBL] [Abstract][Full Text] [Related]
23. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.
Gazit D; Tieder M; Liberman UA; Passi-Even L; Bab IA
J Clin Endocrinol Metab; 1991 Jan; 72(1):229-35. PubMed ID: 1986023
[TBL] [Abstract][Full Text] [Related]
24. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.
Hahn TJ; Scharp CR; Halstead LR; Haddad JG; Karl DM; Avioli LV
J Clin Endocrinol Metab; 1975 Nov; 41(5):926-37. PubMed ID: 1184724
[TBL] [Abstract][Full Text] [Related]
26. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
[TBL] [Abstract][Full Text] [Related]
27. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
28. A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: implications for correct diagnosis and treatment.
Tieder M; Arie R; Bab I; Maor J; Liberman UA
Nephron; 1992; 62(2):176-81. PubMed ID: 1436310
[TBL] [Abstract][Full Text] [Related]
29. Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets.
Insogna KL; Broadus AE; Gertner JM
J Clin Invest; 1983 Jun; 71(6):1562-9. PubMed ID: 6306051
[TBL] [Abstract][Full Text] [Related]
30. [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)].
Schabel F; Kurz R; Madreiter H; Reinken L; Zieglauer H
Padiatr Padol; 1977; 12(2):152-7. PubMed ID: 193082
[TBL] [Abstract][Full Text] [Related]
31. Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy.
McKenna MJ; Martin-Grace J; Crowley R; Twomey PJ; Kilbane MT
J Bone Miner Metab; 2019 Jul; 37(4):685-693. PubMed ID: 30238432
[TBL] [Abstract][Full Text] [Related]
32. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
[TBL] [Abstract][Full Text] [Related]
33. Clinical aspects of X-linked hypophosphatemic rickets.
Chung WT; Niu DM; Lin CY
Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak.
Rendina D; Mossetti G; De Filippo G; Cioffi M; Strazzullo P
J Clin Endocrinol Metab; 2006 Mar; 91(3):959-63. PubMed ID: 16352682
[TBL] [Abstract][Full Text] [Related]
35. Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature.
Tournis ST; Giannikou PV; Paspati IN; Katsalira EA; Voskaki IC; Lyritis GP
J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):150-4. PubMed ID: 15951631
[TBL] [Abstract][Full Text] [Related]
36. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
[TBL] [Abstract][Full Text] [Related]
37. Normal calcitonin stimulation of serum calcitriol in patients with X-linked hypophosphatemic rickets.
Econs MJ; Lobaugh B; Drezner MK
J Clin Endocrinol Metab; 1992 Aug; 75(2):408-11. PubMed ID: 1639943
[TBL] [Abstract][Full Text] [Related]
38. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
Seikaly MG; Quigley R; Baum M
Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
[TBL] [Abstract][Full Text] [Related]
39. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy.
Meyer RA; Tenenhouse HS; Meyer MH; Klugerman AH
J Bone Miner Res; 1989 Aug; 4(4):523-32. PubMed ID: 2816501
[TBL] [Abstract][Full Text] [Related]
40. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
